314 related articles for article (PubMed ID: 31563214)
1. Hepatic Encephalopathy Challenges, Burden, and Diagnostic and Therapeutic Approach.
Yanny B; Winters A; Boutros S; Saab S
Clin Liver Dis; 2019 Nov; 23(4):607-623. PubMed ID: 31563214
[TBL] [Abstract][Full Text] [Related]
2. Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.
Alsahhar JS; Rahimi RS
Curr Opin Gastroenterol; 2019 May; 35(3):145-154. PubMed ID: 30893082
[TBL] [Abstract][Full Text] [Related]
3. Treatment of Overt Hepatic Encephalopathy.
Sussman NL
Clin Liver Dis; 2015 Aug; 19(3):551-63. PubMed ID: 26195208
[TBL] [Abstract][Full Text] [Related]
4. Management of hepatic encephalopathy in the hospital.
Leise MD; Poterucha JJ; Kamath PS; Kim WR
Mayo Clin Proc; 2014 Feb; 89(2):241-53. PubMed ID: 24411831
[TBL] [Abstract][Full Text] [Related]
5. Hepatic encephalopathy: nomenclature, pathogenesis and treatment.
Quero Guillén JC; Carmona Soria I; García Montes JM; Jiménez Sáenz M; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2003 Feb; 95(2):135-42, 127-34. PubMed ID: 12760720
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes of Oral Zinc Therapy in Hepatic Encephalopathy Treatment.
Fritz MK; Mangino AA; Hunt TV; Pitcock CT; Dugan AJ; Karri K; Yarra P
Ann Pharmacother; 2023 Aug; 57(8):899-906. PubMed ID: 36367093
[TBL] [Abstract][Full Text] [Related]
7. Hepatic Encephalopathy-Related Hospitalizations in Cirrhosis: Transition of Care and Closing the Revolving Door.
Frenette CT; Levy C; Saab S
Dig Dis Sci; 2022 Jun; 67(6):1994-2004. PubMed ID: 34169435
[TBL] [Abstract][Full Text] [Related]
8. Update on the Therapeutic Management of Hepatic Encephalopathy.
Kornerup LS; Gluud LL; Vilstrup H; Dam G
Curr Gastroenterol Rep; 2018 Apr; 20(5):21. PubMed ID: 29644492
[TBL] [Abstract][Full Text] [Related]
9. The Health Care Burden of Hepatic Encephalopathy.
Elsaid MI; John T; Li Y; Pentakota SR; Rustgi VK
Clin Liver Dis; 2020 May; 24(2):263-275. PubMed ID: 32245532
[TBL] [Abstract][Full Text] [Related]
10. Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy.
Flamm SL
Am J Med Sci; 2018 Sep; 356(3):296-303. PubMed ID: 30286824
[TBL] [Abstract][Full Text] [Related]
11. Overt Hepatic Encephalopathy: Current Pharmacologic Treatments and Improving Clinical Outcomes.
Rahimi RS; Brown KA; Flamm SL; Brown RS
Am J Med; 2021 Nov; 134(11):1330-1338. PubMed ID: 34242619
[TBL] [Abstract][Full Text] [Related]
12. [Hepatic encephalopathy].
Maruyama K; Shirakura K
Ryoikibetsu Shokogun Shirizu; 2003; (40):466-70. PubMed ID: 14626162
[No Abstract] [Full Text] [Related]
13. Comparison of Rifaximin Plus Lactulose with the Lactulose Alone for the Treatment of Hepatic Encephalopathy.
Ahire K; Sonawale A
J Assoc Physicians India; 2017 Aug; 65(8):42-46. PubMed ID: 28799305
[TBL] [Abstract][Full Text] [Related]
14. Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?
Gluud LL; Dam G; Borre M; Les I; Cordoba J; Marchesini G; Aagaard NK; Vilstrup H
Metab Brain Dis; 2013 Jun; 28(2):221-5. PubMed ID: 23275147
[TBL] [Abstract][Full Text] [Related]
15. Nontraditional Treatment of Hepatic Encephalopathy.
Singh J; Ibrahim B; Han SH
Clin Liver Dis; 2024 May; 28(2):297-315. PubMed ID: 38548441
[TBL] [Abstract][Full Text] [Related]
16. Hepatic Encephalopathy: Diagnostic Tools and Management Strategies.
Badal BD; Bajaj JS
Med Clin North Am; 2023 May; 107(3):517-531. PubMed ID: 37001951
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic Management of Hepatic Encephalopathy.
Mahpour NY; Pioppo-Phelan L; Reja M; Tawadros A; Rustgi VK
Clin Liver Dis; 2020 May; 24(2):231-242. PubMed ID: 32245530
[TBL] [Abstract][Full Text] [Related]
18. Hospitalizations and healthcare costs associated with rifaximin versus lactulose treatment among commercially insured patients with hepatic encephalopathy in the United States.
Volk ML; Burne R; Guérin A; Shi S; Joseph GJ; Heimanson Z; Ahmad M
J Med Econ; 2021; 24(1):202-211. PubMed ID: 33464935
[TBL] [Abstract][Full Text] [Related]
19. Pharmacotherapy for hyperammonemia.
Hadjihambi A; Khetan V; Jalan R
Expert Opin Pharmacother; 2014 Aug; 15(12):1685-95. PubMed ID: 25032885
[TBL] [Abstract][Full Text] [Related]
20. Targets to improve quality of care for patients with hepatic encephalopathy: data from a multi-centre cohort.
Bajaj JS; O'Leary JG; Tandon P; Wong F; Kamath PS; Biggins SW; Garcia-Tsao G; Lai J; Fallon MB; Thuluvath PJ; Vargas HE; Maliakkal B; Subramanian RM; Thacker LR; Reddy KR
Aliment Pharmacol Ther; 2019 Jun; 49(12):1518-1527. PubMed ID: 31032966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
